|
1
|
Jayson GC, Kohn EC, Kitchener HC and
Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Q, Bu S, Xin D, Li B, Wang L and Lai
D: Autophagy is indispensable for the self-renewal and quiescence
of ovarian cancer spheroid cells with stem cell-like properties.
Oxid Med Cell Longev. 2018:70104722018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
You Y, Li Y, Li M, Lei M, Wu M, Qu Y, Yuan
Y, Chen T and Jiang H: Ovarian cancer stem cells promote tumour
immune privilege and invasion via CCL5 and regulatory T cells. Clin
Exp Immunol. 191:60–73. 2018. View Article : Google Scholar
|
|
4
|
Jeong JY, Kang H, Kim TH, Kim G, Heo JH,
Kwon AY, Kim S, Jung SG and An HJ: MicroRNA-136 inhibits cancer
stem cell activity and enhances the anti-tumor effect of paclitaxel
against chemoresistant ovarian cancer cells by targeting Notch3.
Cancer Lett. 386:168–178. 2017. View Article : Google Scholar
|
|
5
|
Liao J, Qian F, Tchabo N,
Mhawech-Fauceglia P, Beck A, Qian Z, Wang X, Huss WJ, Lele SB,
Morrison CD, et al: Ovarian cancer spheroid cells with stem
cell-like properties contribute to tumor generation, metastasis and
chemotherapy resistance through hypoxia-resistant metabolism. PLoS
One. 9:e849412014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang L, Mezencev R, Bowen NJ, Matyunina LV
and McDonald JF: Isolation and characterization of stem-like cells
from a human ovarian cancer cell line. Mol Cell Biochem.
363:257–268. 2012. View Article : Google Scholar
|
|
7
|
Chen MW, Yang ST, Chien MH, Hua KT, Wu CJ,
Hsiao SM, Lin H, Hsiao M, Su JL and Wei LH: The STAT3-miRNA-92-Wnt
signaling pathway regulates spheroid formation and malignant
progression in ovarian cancer. Cancer Res. 77:1955–1967. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chiriva-Internati M, Weidanz JA, Yu Y,
Frezza EE, Jenkins MR, Kennedy RC, Cobos E and Kast WM: Sperm
protein 17 is a suitable target for adoptive T-cell-based
immunotherapy in human ovarian cancer. J Immunother. 31:693–703.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carlsten M, Björkström NK, Norell H,
Bryceson Y, van Hall T, Baumann BC, Hanson M, Schedvins K,
Kiessling R, Ljunggren HG, et al: DNAX accessory molecule-1
mediated recognition of freshly isolated ovarian carcinoma by
resting natural killer cells. Cancer Res. 67:1317–1325. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Law KS, Chen HC and Liao SK: Non-cytotoxic
and sublethal paclitaxel treatment potentiates the sensitivity of
cultured ovarian tumor SKOV-3 cells to lysis by
lymphokine-activated killer cells. Anticancer Res. 27:841–850.
2007.PubMed/NCBI
|
|
11
|
Chan JK, Hamilton CA, Cheung MK, Karimi M,
Baker J, Gall JM, Schulz S, Thorne SH, Teng NN, Contag CH, et al:
Enhanced killing of primary ovarian cancer by retargeting
autologous cytokine-induced killer cells with bispecific
antibodies: A preclinical study. Clin Cancer Res. 12:1859–1867.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu J, Li H, Cao S, Zhang X, Yu J, Qi J,
An X, Yu W, Ren X and Hao X: Maintenance therapy with autologous
cytokine-induced killer cells in patients with advanced epithelial
ovarian cancer after first-line treatment. J Immunother.
37:115–122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt-Wolf IG, Negrin RS, Kiem HP, Blume
KG and Weissman IL: Use of a SCID mouse/human lymphoma model to
evaluate cytokine-induced killer cells with potent antitumor cell
activity. J Exp Med. 174:139–149. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rong X, Wei F, Li A, Xiao D and Luo R:
Effective activity of cytokine induced killer cells against
hepatocellular carcinoma including tumor-initiating cells. Med
Hypotheses. 84:159–161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Ma L, Lai D, Liu T, Cheng W and Guo L:
Cancer stem-like cells can be isolated with drug selection in human
ovarian cancer cell line SKOV3. Acta Biochim Biophys Sin
(Shanghai). 42:593–602. 2010. View Article : Google Scholar
|
|
17
|
Luo X, Dong Z, Chen Y, Yang L and Lai D:
Enrichment of ovarian cancer stem-like cells is associated with
epithelial to mesenchymal transition through an miRNA-activated AKT
pathway. Cell Prolif. 46:436–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Condello S, Morgan CA, Nagdas S, Cao L,
Turek J, Hurley TD and Matei D: β-catenin-regulated ALDH1A1 is a
target in ovarian cancer spheroids. Oncogene. 34:2297–2308. 2015.
View Article : Google Scholar
|
|
19
|
Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J,
Kruk PA, Wenham RM, Nicosia SV, Lancaster JM, Sellers TA, et al:
MicroRNA MiR-214 regulates ovarian cancer cell stemness by
targeting p53/Nanog. J Biol Chem. 291:228512016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmidt-Wolf IG, Lefterova P, Mehta BA,
Fernandez LP, Huhn D, Blume KG, Weissman IL and Negrin RS:
Phenotypic characterization and identification of effector cells
involved in tumor cell recognition of cytokine-induced killer
cells. Exp Hematol. 21:1673–1679. 1993.PubMed/NCBI
|
|
21
|
Qin J, Liu Y, Lu Y, Liu M, Li M, Li J and
Wu L: Hypoxia-inducible factor 1 alpha promotes cancer stem
cells-like properties in human ovarian cancer cells by upregulating
SIRT1 expression. Sci Rep. 7:105922017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Winning S, Splettstoesser F, Fandrey J and
Frede S: Acute hypoxia induces HIF-independent monocyte adhesion to
endothelial cells through increased intercellular adhesion
molecule-1 expression: The role of hypoxic inhibition of prolyl
hydroxylase activity for the induction of NF-kappa B. J Immunol.
185:1786–1793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park KH, Lee TH, Kim CW and Kim J:
Enhancement of CCL15 expression and monocyte adhesion to
endothelial cells (ECs) after hypoxia/reoxygenation and induction
of ICAM-1 expression by CCL15 via the JAK2/STAT3 pathway in ECs. J
Immunol. 190:6550–6558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goebeler M, Meinardus-Hager G, Roth J,
Goerdt S and Sorg C: Nickel chloride and cobalt chloride, two
common contact sensitizers, directly induce expression of
intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion
molecule-1 (VCAM-1), and endothelial leukocyte adhesion molecule
(ELAM-1) by endothelial cells. J Invest Dermatol. 100:759–765.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kawczyk-Krupka A, Czuba ZP, Kwiatek B,
Kwiatek S, Krupka M and Sieroń K: The effect of ALA-PDT under
normoxia and cobalt chloride (CoCl2)-induced hypoxia on
adhesion molecules (ICAM-1, VCAM-1) secretion by colorectal cancer
cells. Photodiagn Photodyn Ther. 19:103–115. 2017. View Article : Google Scholar
|
|
26
|
Rynne-Vidal A, Au-Yeung CL,
Jiménez-Heffernan JA, Pérez-Lozano ML, Cremades-Jimeno L, Bárcena
C, Cristóbal-García I, Fernández-Chacón C, Yeung TL, Mok SC, et al:
Mesothelial-to-mesenchymal transition as a possible therapeutic
target in peritoneal metastasis of ovarian cancer. J Pathol.
242:140–151. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan XY, Zhang Y, Zhang JJ, Zhang LC, Liu
YN, Wu Y, Xue YN, Lu SY, Su J and Sun LK: p62/SQSTM1 as an
oncotarget mediates cisplatin resistance through activating
RIP1-NF-κB pathway in human ovarian cancer cells. Cancer Sci.
108:1405–1413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carduner L, Picot CR, Leroy-Dudal J, Blay
L, Kellouche S and Carreiras F: Cell cycle arrest or survival
signaling through αv integrins, activation of PKC and ERK1/2 lead
to anoikis resistance of ovarian cancer spheroids. Exp Cell Res.
320:329–342. 2014. View Article : Google Scholar
|
|
29
|
Aust S, Felix S, Auer K, Bachmayr-Heyda A,
Kenner L, Dekan S, Meier SM, Gerner C, Grimm C and Pils D: Absence
of PD-L1 on tumor cells is associated with reduced MHC I expression
and PD-L1 expression increases in recurrent serous ovarian cancer.
Sci Rep. 7:429292017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Woo EY, Chu CS, Goletz TJ, Schlienger K,
Yeh H, Coukos G, Rubin SC, Kaiser LR and June CH: Regulatory
CD4(+)CD25(+) T cells in tumors from patients with early-stage
non-small cell lung cancer and late-stage ovarian cancer. Cancer
Res. 61:4766–4772. 2001.PubMed/NCBI
|
|
31
|
Peng J, Hamanishi J, Matsumura N, Abiko K,
Murat K, Baba T, Yamaguchi K, Horikawa N, Hosoe Y, Murphy SK, et
al: Chemotherapy induces programmed cell death-ligand 1
overexpression via the nuclear factor-κB to foster an
immunosuppressive tumor microenvironment in ovarian cancer. Cancer
Res. 75:5034–5045. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gammaitoni L, Giraudo L, Macagno M, Leuci
V, Mesiano G, Rotolo R, Sassi F, Sanlorenzo M, Zaccagna A, Pisacane
A, et al: Cytokine-induced killer cells kill chemo-surviving
melanoma cancer stem cells. Clin Cancer Res. 23:2277–2288. 2017.
View Article : Google Scholar
|
|
33
|
Rong XX, Wei F, Lin XL, Qin YJ, Chen L,
Wang HY, Shen HF, Jia LT, Xie RY, Lin TY, et al: Recognition and
killing of cancer stem-like cell population in hepatocellular
carcinoma cells by cytokine-induced killer cells via NKG2d-ligands
recognition. OncoImmunology. 5:e10860602015. View Article : Google Scholar
|
|
34
|
Long EO: ICAM-1: Getting a grip on
leukocyte adhesion. J Immunol. 186:5021–5023. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Arnold JM, Cummings M, Purdie D and
Chenevix-Trench G: Reduced expression of intercellular adhesion
molecule-1 in ovarian adenocarcinomas. Br J Cancer. 85:1351–1358.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
de Groote ML, Kazemier HG, Huisman C, van
der Gun BT, Faas MM and Rots MG: Upregulation of endogenous ICAM-1
reduces ovarian cancer cell growth in the absence of immune cells.
Int J Cancer. 134:280–290. 2014. View Article : Google Scholar
|
|
37
|
Barsoum IB, Hamilton TK, Li X, Cotechini
T, Miles EA, Siemens DR and Graham CH: Hypoxia induces escape from
innate immunity in cancer cells via increased expression of ADAM10:
Role of nitric oxide. Cancer Res. 71:7433–7441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Terry S, Buart S, Tan TZ, Gros G, Noman
MZ, Lorens JB, Mami-Chouaib F, Thiery JP and Chouaib S: Acquisition
of tumor cell phenotypic diversity along the EMT spectrum under
hypoxic pressure: Consequences on susceptibility to cell-mediated
cytotoxicity. OncoImmunology. 6:e12718582017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wan J, Wu W, Che Y, Kang N and Zhang R:
Low dose photodynamic-therapy induce immune escape of tumor cells
in a HIF-1α dependent manner through PI3K/Akt pathway. Int
Immunopharmacol. 28:44–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lee YH, Bae HC, Noh KH, Song KH, Ye SK,
Mao CP, Lee KM, Wu TC and Kim TW: Gain of HIF-1α under normoxia in
cancer mediates immune adaptation through the AKT/ERK and VEGFA
axes. Clin Cancer Res. 21:1438–1446. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lu Y, Hu J, Sun W, Duan X and Chen X:
Hypoxia-mediated immune evasion of pancreatic carcinoma cells. Mol
Med Rep. 11:3666–3672. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wei F, Rong XX, Xie RY, Jia LT, Wang HY,
Qin YJ, Chen L, Shen HF, Lin XL, Yang J, et al: Cytokine-induced
killer cells efficiently kill stem-like cancer cells of
nasopharyngeal carcinoma via the NKG2D-ligands recognition.
Oncotarget. 6:35023–35039. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sawada T1, Kimura K, Nishihara T, Onoda N,
Teraoka H, Yamashita Y, Yamada N, Yashiro M, Ohira M and Hirakawa
K: TGF-beta1 down-regulates ICAM-1 expression and enhances liver
metastasis of pancreatic cancer. Adv Med Sci. 51:60–65. 2006.
|
|
44
|
Bessa X, Elizalde JI, Mitjans F, Piñol V,
Miquel R, Panés J, Piulats J, Piqué JM and Castells A: Leukocyte
recruitment in colon cancer: Role of cell adhesion molecules,
nitric oxide, and transforming growth factor beta1.
Gastroenterology. 122:1122–1132. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ohga E and Matsuse T: The relationship
between adhesion molecules and hypoxia. Nihon Rinsho. 58:1587–1591.
2000.In Japanese. PubMed/NCBI
|
|
46
|
Thichanpiang P, Harper SJ, Wongprasert K
and Bates DO: TNF-α-induced ICAM-1 expression and monocyte adhesion
in human RPE cells is mediated in part through autocrine VEGF
stimulation. Mol Vis. 20:781–789. 2014.
|
|
47
|
Li J, Chen L, Xiong Y, Zheng X, Xie Q,
Zhou Q, Shi L, Wu C, Jiang J and Wang H: Knockdown of PD-L1 in
human gastric cancer cells inhibits tumor progression and improves
the cytotoxic sensitivity to CIK therapy. Cell Physiol Biochem.
41:907–920. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen CL, Pan QZ, Zhao JJ, Wang Y, Li YQ,
Wang QJ, Pan K, Weng DS, Jiang SS, Tang Y, et al: PD-L1 expression
as a predictive biomarker for cytokine-induced killer cell
immunotherapy in patients with hepatocellular carcinoma.
OncoImmunology. 5:e11766532016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ren X, Ma W, Lu H, Yuan L, An L, Wang X,
Cheng G and Zuo S: Modification of cytokine-induced killer cells
with chimeric antigen receptors (CARs) enhances antitumor immunity
to epidermal growth factor receptor (EGFR)-positive malignancies.
Cancer Immunol Immunother. 64:1517–1529. 2015. View Article : Google Scholar : PubMed/NCBI
|
